Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Change in Receivables (2016 - 2025)

Merit Medical Systems' Change in Receivables history spans 15 years, with the latest figure at -$18.0 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 534.73% year-over-year to -$18.0 million; the TTM value through Dec 2025 reached -$4.4 million, down 131.92%, while the annual FY2025 figure was -$4.4 million, 131.92% down from the prior year.
  • Change in Receivables for Q4 2025 was -$18.0 million at Merit Medical Systems, down from $6.3 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $20.8 million in Q4 2022 and bottomed at -$18.0 million in Q4 2025.
  • The 5-year median for Change in Receivables is $3.3 million (2021), against an average of $1.5 million.
  • The largest annual shift saw Change in Receivables surged 1193.37% in 2021 before it crashed 756.88% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $5.4 million in 2021, then soared by 281.73% to $20.8 million in 2022, then plummeted by 130.22% to -$6.3 million in 2023, then surged by 166.01% to $4.1 million in 2024, then plummeted by 534.73% to -$18.0 million in 2025.
  • Per Business Quant, the three most recent readings for MMSI's Change in Receivables are -$18.0 million (Q4 2025), $6.3 million (Q3 2025), and $7.0 million (Q2 2025).